SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-045763
Filing Date
2017-07-19
Accepted
2017-07-19 16:05:59
Documents
3
Period of Report
2017-07-19
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-18118_18k.htm 8-K 31592
2 EX-3.1 a17-18118_1ex3d1.htm EX-3.1 39247
3 EX-3.2 a17-18118_1ex3d2.htm EX-3.2 231202
  Complete submission text file 0001104659-17-045763.txt   303237
Mailing Address 2855 GAZELLE CT CARLSBAD CA 92010
Business Address 55 CAMBRIDGE PARKWAY SUITE 100 CAMBRIDGE MA 02142 760-603-2732
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38137 | Film No.: 17972390
SIC: 2834 Pharmaceutical Preparations